Latest Enterprise software Startup Funding Rounds
Software companies helping organisations run their operations, serve customers and get work done.
- Rounds
- 2,267 Jan 1 – Oct 24, 2026
- Disclosed funding
- $127B 1911 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C CORCompany profile AI-powered project profitability platform for agencies and professional services firms. AI-powered project profitability platform for agencies and professional services firms. | $30M | Growth | Enterprise software | United States | Investors | |
| G GreyparrotCompany profile Greyparrot is an AI waste intelligence company that helps measure and manage waste. Greyparrot is an AI waste intelligence company that helps measure and manage waste. | $27M | Series B | Enterprise software, Climate tech | United Kingdom | Investors | |
| H Healia is a healthcare benefits platform built for dual-income families. | $14M | Series A | Enterprise software, Fintech | United States | Investors | |
| g Full-stack observability platform for engineers & agents | $100M | Series CSeries C+ | Enterprise software, Developer tools | United States | Investors | |
| E EinshipCompany profile Einship provides market intelligence and operational software for importers, exporters and logistics companies. Einship provides market intelligence and operational software for importers, exporters and logistics companies. | $1M | Seed | Enterprise software, Logistics | Brazil | Investors | |
FrenosCompany profile Develops AI-based tools that continuously validate operational-technology security posture. Develops AI-based tools that continuously validate operational-technology security posture. | $1.5M | Seed+Seed | Enterprise software, Cybersecurity | United States | Investors | |
| TP Torrey Pines MedicineCompany profile Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases | Undisclosed | Pre-SeedPre-seed | Enterprise software, Biotech | China | Investors | |
Curant.ai develops AI software for insurance claims. | $3.1M | Seed | Enterprise software, Fintech | United States | Investors | |
| P America's first federally regulated sports-native prediction market | $35M | Growth | Enterprise software, Fintech | United States | Investors | |
| M MiraeCompany profile AI-driven continuous care platform for autoimmune disease and other complex chronic conditions AI-driven continuous care platform for autoimmune disease and other complex chronic conditions | $5.4M | Seed | Enterprise software, Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Blacksmith, Databuddy Analytics, Clueso
108rounds1led - 2General Catalyst
Legora, Different, Melius
63rounds7led - 3Lightspeed
Different, Zenzap, Zomint
61rounds3led - 4Andreessen Horowitz (a16z)
ASI, Town, EliseAI
59rounds6led - 5Accel
Coast, Legora, RapidCanvas
49rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.